Related references
Note: Only part of the references are listed.Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
Motives and Side-Effects of Microdosing With Psychedelics Among Users
Nadia R. P. W. Hutten et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration
James Fadiman et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2019)
Narrative identity, rationality, and microdosing classic psychedelics
Megan Webb et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2019)
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman et al.
FRONTIERS IN PHARMACOLOGY (2018)
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial
Michael C. Mithoefer et al.
LANCET PSYCHIATRY (2018)
Powerful substances in tiny amounts: An interview study of psychedelic microdosing
Petter Grahl Johnstad
NORDIC STUDIES ON ALCOHOL AND DRUGS (2018)
DSM-5 Changes in Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder: Implications for Comorbid Sleep Issues
Ujjwal P. Ramtekkar
CHILDREN-BASEL (2017)
Neuroticism is associated with challenging experiences with psilocybin mushrooms
Frederick S. Barrett et al.
PERSONALITY AND INDIVIDUAL DIFFERENCES (2017)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
The co-occurrence of autism and attention deficit hyperactivity disorder in children - what do we know?
Yael Leitner
FRONTIERS IN HUMAN NEUROSCIENCE (2014)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
The safety and efficacy of ± 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
EEG in adults with Attention-Deficit/Hyperactivity Disorder
Adam R. Clarke et al.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2008)
Testing the tripartite model in young adolescents: Is hyperarousal specific for anxiety and not depress ion?
Kirstin Greaves-Lord et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Lifetime prevalence and age-of-onset distributions' of DSM-IV disorders in the national comorbidity survey replication
RC Kessler et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Share Paper
